Use of del Nido cardioplegia for adult cardiac surgery at the Cleveland Clinic: Perfusion implications

Journal of Extra-Corporeal Technology

Volumn 46, Issue 4, 2014, Pages 317-323

  Kim, Kuna ^a   Ball, Clifford ^a   Grady, Patrick ^a   Mick, Stephanie ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Del nido solution; Myocardial protection and cardioplegia

Indexed keywords

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CARDIOPLEGIA; CARDIOVASCULAR THERAPEUTIC DEVICE; CENTRIFUGAL PUMP; CORONARY ARTERY DISEASE; CRYSTALLOID; DEL NIDO CARDIOPLEGIA; FILTER; HEART ARREST; HEART PROTECTION; HEART SURGERY; HUMAN; OXYGENATOR; ROLLER PUMP; UNITED STATES; DEVICES; HEART; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPERFUSION;

CARDIOPLEGIC AGENT;

ADULT; CARDIOPLEGIC SOLUTIONS; HEART; HEART ARREST, INDUCED; HUMANS; REPERFUSION;

EID: 84919668129     PISSN: None     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, eds. Cardiopulmonary Bypass: Principles and Practice, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:172-9, 702-4.
2. Hensley FA, Martin DE, Gravlee GP. A Practical Approach to Cardiac Anesthesia, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013:649-50.
3. Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg. 2003;75:S661-6.
4. Cohen G, Borger MA, Weisel RD, Rao V. Intraoperative myocardial protection: Current trends and future perspectives. Ann Thorac Surg. 1999;68:1995-2001.
5. Vinten-Johansen J, Thourani VH. Myocardial protection:An overview. J Extra Corpor Technol. 2000;32:38-48.
6. Patent 5,407,793. Alexandria, PA: U.S. Patent and Trademark Office; 1995.
7. Charette K, Gerrah R, Quaegebeur J, et al. Single dose myocardial protection utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion. 2012;27:98-103.
8. Matte GS, Del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol. 2012;44:98-103.
9. O'Brien JD, Howlett SE, Burton HJ, O'Blenes SB, Litz DS, Friesen CL. Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg. 2009;87:1517-23.
10. Govindapillai A, Hua R, Rose R, Friesen CH, O'Blenes SB. Protecting the aged heart during cardiac surgery: Use of del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg. 2013;146:940-8.
11. O'Blenes SB, Friesen CH, Ali A, Howlett S. Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg. 2011;141:762-9.
12. Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG, Johnston DR, Blackstone EH, Sabik JF. Del nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thoracic Cardiovasc Surg. 2014. In press, Published online 22 October 2014. Available at: http://www.sciencedirect.com/science/article/pii/S0022522314015943.
13. Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg. 1987;93:127-39.
14. Pisano GP, Bohmer RM. Organizational differences in rates of learning: Evidence from the adoption of minimally invasive cardiac surgery. Manage Sci. 2001;47:752-68.
15. Iribarne A, Easterwood R, Chan EY, et al. The golden age of minimally invasive cardiothoracic surgery: Current and future perspectives. Future Cardiol. 2011;7:333-46.
16. Chitwood WR Jr, Elbeery JR, Moran JF. Minimally invasive mitral valve repair: Using a minithoracotomy and transthoracic aortic occlusion. Ann Thorac Surg. 1997;63:1477-9.